The FDA Approval of a ‘Covid Pill’ Would Be a Gamechanger. But Isn’t There Already One on the Market?

A COVID-19 pill is poised to hit the U.S. market after a Food and Drug Administration panel narrowly recommended that Merck's drug Molnupiravir be granted Emergency Use Authorization.

The FDA panel voted 13-10 that the antiviral drug’s benefits outweigh its risks. If the FDA grants the EUA, Molnu...